Memorial Sloan Kettering Cancer Center Experts to Present Noteworthy Research at the American Association for Cancer Research (AACR) 2023 Annual Meeting

Memorial Sloan Kettering Cancer Center Experts to Present Noteworthy Research at the American Association for Cancer Research (AACR) 2023 Annual Meeting

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the American Association for Cancer Research (AACR) Annual Meeting on April 14-19 in Orlando, Florida.

MSK experts will present significant research and will be available to comment on topics including cancer disparities, analytical tools for precision medicine, genomic biomarkers, tumor biology, immunology and more.

  • Deb Schrag, MD, MPH, will offer insights on translating knowledge from panels to practice to population health during the opening plenary session on Sunday, April 16, 9:30-11:30 a.m. EDT.
  • Henry Walch, MS, will present novel insights into the genomic basis of racial disparities in colorectal cancer during a highlighted session on cancer disparities on Monday, April 17, 9:00 a.m.-12:30 p.m. EDT.
  • Vinod P. Balachandran, MD, will discuss clinical research updates on individualized mRNA neoantigen vaccines for pancreatic cancer during a session on Advances in Diagnostics & Therapeutics on Tuesday, April 18, 10:15-11:45 a.m. EDT.

Other highlights include:

  • Karuna Ganesh, MD, PhD, will discuss progressive plasticity during colorectal cancer metastasis during a major symposium on Monday, April 17, 12:30-2:00 p.m. EDT.
  • Michael J. Morris, MD, will discuss MSK’s role in the NCI’s Telehealth Research Centers of Excellence (TRACE) Initiative, supported by the Cancer Moonshot, during an NCI-NIH Sponsored session on Monday, April 17, 2:45-3:45 p.m. EDT.
  • Experts will discuss the 25th anniversary of the breakthrough drug trastuzumab (Herceptin®), originally approved for the treatment of HER2-positive metastatic breast cancer, during a major symposium on Monday, April 17, 10:15-11:15 a.m. EDT. Larry Norton, MD, who was instrumental in the development of trastuzumab, is available for comment.

As part of the 2023 AACR Annual Meeting, several MSK faculty have been honored with prestigious awards and lectureships by AACR and the AACR Academy including:

  • Andrea Schietinger, PhD, Associate Member, Immunology Program, Sloan Kettering Institute, will be awarded the AACR-Irving Weinstein Foundation Distinguished Lectureship, in acknowledgment of an individual whose outstanding personal innovation in science and whose position as a thought leader in fields relevant to cancer research has the potential to inspire creative thinking and new directions in cancer research. The recipient is selected by the AACR President.
  • Selwyn M. Vickers, MD, FACS, pancreatic cancer surgeon, researcher, and President & CEO, will receive the AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship, presented to outstanding scientists who have made meritorious contributions to the field of cancer research and who have, through leadership or by example, furthered the advancement of minority investigators in cancer research.

For more information and to set up interviews, contact Nick Gardner, Media Relations, at [email protected] or 917-843-3834.

Follow the meeting live on Twitter using the hashtag #AACR23 and follow MSK on Twitter at @MSKCancerCenter.